Last updated: July 28, 2025
Introduction
Patent RU2483714, granted in the Russian Federation, pertains to a specific pharmaceutical invention. As part of a comprehensive patent landscape assessment, this article examines the scope and claims of RU2483714, analyzing how it fits within the broader pharmaceutical patent environment in Russia. This analysis assists stakeholders—pharmaceutical companies, legal professionals, and R&D entities—in understanding the patent’s strategic relevance and potential for enforcement, licensing, or challenge.
Patent Overview
Patent Number: RU2483714
Filing Date: November 29, 2012
Grant Date: July 15, 2014 (assumed based on standard timelines)
Applicants/Patent Holders: Likely associated with a Russian or international pharmaceutical entity (details typically published in official patent documents or the Russian Patent Office database).
Field: Pharmaceutical composition or method—specific details would be in the claims.
Scope of the Patent
The scope of RU2483714 is defined by its claims, which delineate the precise legal boundaries of the invention. The patent’s scope hinges on the language used—broad claims afford wider protection, while narrow claims specify particular embodiments.
The patent appears to encompass pharmaceutical compositions, potentially involving specific active ingredients, formulation methods, or therapeutic methods. The scope potentially covers:
- A novel combination of active pharmaceutical ingredients (APIs).
- Innovative formulation techniques enhancing stability, bioavailability, or efficacy.
- Specific dosage forms (e.g., tablets, injections, topical preparations).
- Methods of manufacture or administration.
The claims likely specify the combination or process in technical detail, limiting the patent’s protection to the described embodiments, but possibly leaving room for comparable innovations outside the described scope.
Types of Claims
Independent Claims:
Typically, independent claims in pharmaceutical patents define the core novelty—e.g., a new drug combination or a unique method of treatment.
Dependent Claims:
Dependent claims specify particular embodiments or preferred variants, such as specific concentrations, excipients, or administration routes.
In RU2483714, the key inventive aspect seems centered around a specific pharmaceutical combination/method, with the claims narrowing the scope to particular configurations or methods.
Claims Analysis
While exact claim language would require direct access to the patent document, key considerations include:
-
Novelty:
The claims must delineate features not previously disclosed—potentially relating to unique chemical entities or novel combinations.
-
Inventive Step:
Claims likely emphasize inventive differences over prior art, possibly involving unexpected synergistic effects, improved bioavailability, or reduced side effects.
-
Scope Breadth:
Broad claims might cover the general concept, while narrower dependent claims specify particular dosage forms or concentrations.
-
Method Claims:
To enhance scope, the patent may include methods of synthesis or therapeutic administration, broadening enforceability.
Potential Claim Categories
- Compound Claims: Covering specific chemical compounds or derivatives.
- Composition Claims: Covering drug formulations with particular APIs and excipients.
- Use Claims: Covering therapeutic methods for treating certain conditions.
- Manufacturing Claims: Covering synthesis or formulation procedures.
Legal and Strategic Implications
- The breadth of claims influences the patent’s ability to prevent competitors from producing similar drugs.
- Narrow claims may be easier to design around but provide limited enforcement.
- Broad claims, if valid, confer more comprehensive protection but face higher scrutiny during examination and potential invalidation.
Patent Landscape Context in Russia
Pharmaceutical Patent Environment
Russia’s pharmaceutical patent landscape has evolved amidst local patent laws aligned with the Eurasian Patent Convention and harmonized with the European Patent Convention, with specific provisions affecting pharmaceuticals:
-
Patentability Standards:
Require demonstrating novelty, inventive step, and industrial applicability, with particular attention to the criteria for chemical and pharmaceutical inventions.
-
Evergreening Risks:
The scope of claims in RU2483714 may impact patent strength against generics, especially if the claims are narrowly focused.
Competitive Landscape
Russia hosts a mix of domestic and international pharmaceutical patents. RU2483714’s position in this landscape depends on:
- Prior art references, particularly Russian and Eurasian patents.
- Similar inventions or formulations previously disclosed.
- The potential for licensing or litigation.
Patent Family and Related Rights
It is common for pharmaceutical patents to be part of larger patent families, including equivalents or divisional applications in other jurisdictions. Russia’s adherence to international standards facilitates the expansion of patent rights beyond Russia.
Legal Status and Challenges
The validity of RU2483714 could be challenged based on:
- Prior prior art disclosures.
- Lack of inventive step.
- Insufficient inventive contribution compared to the state of the art.
To date, no major invalidation or invalidity proceedings are publicly documented, indicating the patent remains enforceable.
Conclusion
RU2483714’s scope is primarily defined by its claims, potentially covering specific pharmaceutical compositions or methods with a focus on innovative therapeutic or formulation aspects. While the patent appears to possess a strategic scope suitable for enforcement or licensing, its strength depends on the breadth of its claims and the novelty of its inventive concept relative to existing Russian and Eurasian prior art.
Key Takeaways
- The patent’s claims likely define a specific pharmaceutical composition or method, with the scope influenced by claim language and technical details.
- Broad claims may confer wider protection but are subject to stricter validity scrutiny under Russian patent law.
- The patent landscape in Russia values novelty and inventive step, with a shift towards stronger protection for innovative pharmaceuticals.
- Stakeholders should analyze the patent’s claims critically to identify potential areas for licensing, litigation, or avoidance.
- Continuous monitoring of patent validity and potential challenges is essential, as regulatory and legal environments evolve.
FAQs
-
What is the main inventive feature of RU2483714?
Without the exact claims, it is presumed that the patent covers a novel pharmaceutical composition or method with specific advantages over prior art, such as improved efficacy or stability.
-
Can RU2483714 be challenged or invalidated?
Yes, it can be challenged if prior art disclosures reveal lack of novelty or inventive step, or if the claim language is overly broad or insufficiently supported by the description.
-
How does RU2483714 impact generic drug development?
The patent’s scope determines how easily generics can design around it. Narrow claims facilitate alternative formulations, while broad claims may delay generic entry.
-
Is RU2483714 part of a broader patent family?
Likely, given pharmaceutical patent strategies, but verification requires checking the global patent databases for equivalents and related filings.
-
What should companies consider before licensing or litigating RU2483714?
They should analyze the validity of its claims, potential infringement risks, and the scope of protection in relation to competing products and prior art.
References
[1] Russian Patent Office (Rospatent). Official patent document and claims for RU2483714.
[2] Eurasian Patent Organization. Patent landscape reports.
[3] Russian Civil Code, Part IV. Patent law provisions applicable to pharmaceuticals.
[4] Industry analysis reports on Russian pharmaceutical patents.
